Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability.
This report contains market size and forecasts of Serotonin Syndrome Treatment in Global, including the following market information:
Global Serotonin Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Serotonin Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serotonin Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Serotonin Syndrome Treatment include AstraZeneca, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Sanofi S.A. and Ciron Drugs & Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Serotonin Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Serotonin Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Serotonin Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)
Serotonin Antagonists
Supportive Care
Gastrointestinal Decontamination
Other
Global Serotonin Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Serotonin Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Use
Clinic Use
Other
Global Serotonin Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Serotonin Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Serotonin Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Serotonin Syndrome Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Eli Lilly and Company
Forest Laboratories
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
Sanofi S.A.
Ciron Drugs & Pharmaceuticals